2 research outputs found
INDIVIDUAL APPROACH TO ULTRA LOSE DOSE REGIME OF MENOPAUSAL HORMONAL THERAPY IN PATIENTS AGED OVER 60
The menopausal hormonal therapy is represented today by ultra low doses in the form of drug Angeliq® Micro, which allows continuing MHT for patients older than 60-65 and choosing an individual MHT type